News By Tag
News By Place
Follow on Google News
Survey: Employers Not Aware That Tools for Controlling Employee Health Care Costs Can Be Harmful
Step therapy, formulary tiers, prior authorization and specialty pharmacy preferred drugs can be roadblocks to care
Nearly all respondents to CancerCare's 2022 Employer Market Survey of large employers said that step therapy (96%), formulary tiers (94%), prior authorizations (94%) and specialty pharmacy preferred drug lists (92%) were very or somewhat effective in controlling costs for employees. The survey also found that a substantial number of respondents do not perceive UM tools as barriers to employees receiving the care they need, when they need it. More than half (62%) say formulary tiers are not a barrier to care; 60% feel that the appeals process is not a barrier; 55% say step therapy is not a barrier; and 49% feel that specialty pharmacy preferred drug lists are not barriers. Many employers are unaware that, in reality, these cost-cutting measures can backfire -- causing treatment delays, higher out-of-pocket costs, and non-adherence to medication, especially for individuals with serious and chronic health conditions.
"The biggest challenge employers face is designing high quality and cost-effective health plans that don't create roadblocks to needed care," explains Patricia Goldsmith, Chief Executive Officer, Cancer (https://www.cancercare.org/
UM tactics like step therapy, formulary tiers, prior authorization and specialty pharmacy preferred drug lists may seem like attractive elements of a health plan. But as the CancerCare survey shows, many employers are unaware that these techniques can negatively impact outcomes for sick employees by causing delays to care, higher out-of-pocket costs, limited choices, and can lead to higher medical benefit costs.
"Keeping a lid on soaring healthcare costs should not be done by reducing access to needed care," said Goldsmith. "With a better understanding of the unintended consequences of utilization management, employers can design benefit plans that allow their employees access to prompt and effective treatments while controlling overall healthcare costs."
CancerCare recently published "The Employers' Prescription for Employee Protection Toolkit: Best Practices for Prescription Drug Benefit Design (https://www.cancercare.org/
A total of 50 executives who are responsible for employee benefits, from 50 different large US employers, participated in the January 2022 CancerCare Employer Market Survey. Respondents' companies employ over 250,000 employees.
Account Email Address Account Phone Number Disclaimer Report Abuse